前列腺癌
药物输送
靶向给药
药品
体内
癌症研究
细胞毒性
癌细胞
癌症
噬菌体展示
肽
药理学
生物
体外
计算生物学
化学
医学
内科学
生物化学
生物技术
有机化学
作者
Anna Cohen,Maysoon Kashkoosh,Vipin Sharma,Akash Panja,Sagi Arieh Shpitzer,Shay Golan,Andrii Bazylevich,Gary Gellerman,Galia Luboshits,Michael A. Firer
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2025-07-01
卷期号:17 (7): 866-866
被引量:4
标识
DOI:10.3390/pharmaceutics17070866
摘要
Background: Metastatic prostate cancer (mPrC), with a median survival of under 2 years, represents an important unmet medical need which may benefit from the development of more effective targeted drug delivery systems. Several cell surface receptors have been identified as candidates for targeted drug delivery to mPrC cells; however, these receptors were selected for their overabundance on PrC cells rather than for their suitability for targeted delivery and uptake of cytotoxic drug payloads. Methods: We describe a novel, unbiased strategy to isolate peptides that fulfill functional criteria required for effective intracellular drug delivery and the specific cytotoxicity of PrC cells without prior knowledge of the targeted receptor. Phage clones displaying 7-mer cyclic peptides were negatively selected in vivo and then positively biopanned through a series of parent and drug-resistant mPrC cells. Peptides from the internalized clones were then subjected to a panel of biochemical and functional tests that led to the selection of several peptide candidates. Results: The selected peptides do not bind PSMA. Peptide-drug conjugates (PDCs) incorporating one of the peptides selectively killed wild-type and drug-resistant PrC cell lines and patient PrC cells but not normal prostate tissue cells in vitro. The PDC also halted the growth of PC3 tumors in a xenograft model. Conclusions: Our study demonstrates that adding unbiased, functional criteria into drug carrier selection protocols can lead to the discovery of novel peptides with appropriate properties required for effective targeted drug delivery into target cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI